A citation-based method for searching scientific literature

M P Rubtsova, D P Vasilkova, A N Malyavko, Yu V Naraikina, M I Zvereva, O A Dontsova. Acta Naturae 2012
Times Cited: 25







List of co-cited articles
121 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oxidative stress shortens telomeres.
Thomas von Zglinicki. Trends Biochem Sci 2002
16



Telomerase RNA biosynthesis and processing.
E M Smekalova, O S Shubernetskaya, M I Zvereva, E V Gromenko, M P Rubtsova, O A Dontsova. Biochemistry (Mosc) 2012
27
12

A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.
Andrew S Venteicher, Eladio B Abreu, Zhaojing Meng, Kelly E McCann, Rebecca M Terns, Timothy D Veenstra, Michael P Terns, Steven E Artandi. Science 2009
354
12


Telomerase in the human organism.
Kathleen Collins, James R Mitchell. Oncogene 2002
431
12


Structure and function of telomeres.
E H Blackburn. Nature 1991
12

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
8

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.
Christian Koelsche, Felix Sahm, David Capper, David Reuss, Dominik Sturm, David T W Jones, Marcel Kool, Paul A Northcott, Benedikt Wiestler, Katja Böhmer,[...]. Acta Neuropathol 2013
199
8

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
163
8

Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
Kathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, Eshini Panditharatna, Charles B Stevenson, Sharon L Gardner, Mariko D Dewire, Christopher R Pierson, Randal Olshefski, Sandra A Rempel,[...]. J Neurooncol 2014
27
8


Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
595
8

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
308
8

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Marcel Kool, Jan Koster, Jens Bunt, Nancy E Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N Caron, Jacqueline Cloos,[...]. PLoS One 2008
502
8

Telomeric armor: the layers of end protection.
Liana Oganesian, Jan Karlseder. J Cell Sci 2009
38
8

Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET).
Kevin C De Braganca, Roger J Packer. Curr Treat Options Neurol 2013
27
8

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
366
8

Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
668
8

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
899
8

Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.
Harikleia Episkopou, Irena Draskovic, Amandine Van Beneden, Gaëlle Tilman, Marina Mattiussi, Matthieu Gobin, Nausica Arnoult, Arturo Londoño-Vallejo, Anabelle Decottignies. Nucleic Acids Res 2014
107
8

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
8

Molecular diagnostics in paediatric glial tumours.
Joon-Hyung Kim, Jason T Huse, Yujie Huang, David Lyden, Jeffrey P Greenfield. Lancet Oncol 2013
8
25

Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency.
Oliver E Bechter, Ying Zou, Jerry W Shay, Woodring E Wright. EMBO Rep 2003
51
8

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Marc Remke, Vijay Ramaswamy, John Peacock, David J H Shih, Christian Koelsche, Paul A Northcott, Nadia Hill, Florence M G Cavalli, Marcel Kool, Xin Wang,[...]. Acta Neuropathol 2013
105
8

Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
198
8

Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase.
Qing-You Du, Xiao-Bo Wang, Xue-Jun Chen, Wei Zheng, Sheng-Qi Wang. World J Gastroenterol 2003
12
16


Telomerase: structure, functions, and activity regulation.
M I Zvereva, D M Shcherbakova, O A Dontsova. Biochemistry (Mosc) 2010
84
8

The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel.
Erin M Goldblatt, Erin R Gentry, Melanie J Fox, Sergei M Gryaznov, Changyu Shen, Brittney-Shea Herbert. Mol Cancer Ther 2009
42
8

Molecular targeting of cancer: telomeres as targets.
R Hodes. Proc Natl Acad Sci U S A 2001
36
8

Combined effects of Cantide and chemotherapeutic drugs on inhibition of tumor cells' growth in vitro and in vivo.
Ying Yang, Qiu-Jun Lv, Qing-You Du, Bing-Hu Yang, Ru-Xian Lin, Sheng-Qi Wang. World J Gastroenterol 2005
16
12

The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth.
Calin O Marian, Steve K Cho, Brian M McEllin, Elizabeth A Maher, Kimmo J Hatanpaa, Christopher J Madden, Bruce E Mickey, Woodring E Wright, Jerry W Shay, Robert M Bachoo. Clin Cancer Res 2010
146
8

Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria.
Nilesh K Sharma, Aurelio Reyes, Paula Green, Matthieu J Caron, Marcelo G Bonini, Donna M Gordon, Ian J Holt, Janine Hertzog Santos. Nucleic Acids Res 2012
109
8

Specific features of telomerase RNA from Hansenula polymorpha.
Elena M Smekalova, Alexander N Malyavko, Maria I Zvereva, Andrey V Mardanov, Nikolai V Ravin, Konstantin G Skryabin, Eric Westhof, Olga A Dontsova. RNA 2013
11
18

Oxidative stress induces persistent telomeric DNA damage responsible for nuclear morphology change in mammalian cells.
Elisa Coluzzi, Monica Colamartino, Renata Cozzi, Stefano Leone, Carlo Meneghini, Nathan O'Callaghan, Antonella Sgura. PLoS One 2014
102
8

Axis of ageing: telomeres, p53 and mitochondria.
Ergün Sahin, Ronald A DePinho. Nat Rev Mol Cell Biol 2012
219
8

Human telomerase and its regulation.
Yu-Sheng Cong, Woodring E Wright, Jerry W Shay. Microbiol Mol Biol Rev 2002
609
8

A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
8

The RNA component of human telomerase.
J Feng, W D Funk, S S Wang, S L Weinrich, A A Avilion, C P Chiu, R R Adams, E Chang, R C Allsopp, J Yu. Science 1995
8

Telomere structure and telomerase in health and disease (review).
Daniel E Gomez, Romina G Armando, Hernán G Farina, Pablo Lorenzano Menna, Carolina S Cerrudo, P Daniel Ghiringhelli, Daniel F Alonso. Int J Oncol 2012
89
8

Structural identity of telomeric complexes.
Marie-Josèphe Giraud-Panis, Sabrina Pisano, Anaïs Poulet, Marie-Hélène Le Du, Eric Gilson. FEBS Lett 2010
36
8

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
8

Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.
Daniela Fenoglio, Alessia Parodi, Rosa Lavieri, Francesca Kalli, Francesca Ferrera, Augusto Tagliamacco, Andrea Guastalla, Maria Giuseppina Lamperti, Mauro Giacomini, Gilberto Filaci. Hum Vaccin Immunother 2015
24
8


How shelterin protects mammalian telomeres.
Wilhelm Palm, Titia de Lange. Annu Rev Genet 2008
8

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.
Michael Kalos, Bruce L Levine, David L Porter, Sharyn Katz, Stephan A Grupp, Adam Bagg, Carl H June. Sci Transl Med 2011
8

Chimeric antigen receptor T cells for sustained remissions in leukemia.
Shannon L Maude, Noelle Frey, Pamela A Shaw, Richard Aplenc, David M Barrett, Nancy J Bunin, Anne Chew, Vanessa E Gonzalez, Zhaohui Zheng, Simon F Lacey,[...]. N Engl J Med 2014
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.